Hyd-based Austrak launches nephrology and urology division
22 June 2022 | News
To manufacture 73 valued products
Hyderabad-based pharma company Austrak has launched its new super speciality division to focus on around 73 valued products in nephrology and urology. With a strong presence in the segment of ophthalmology for the last 12 years, Austrak aims to supply products and services that significantly improve people's lives by helping to prevent, diagnose and treat disease.
Vittal, Chairman, Austrak said, "We aim to develop and market high-quality speciality, therapeutic and medical products to cure critical illnesses like Chronic Kidney Disease (CKD) and urology-related ailments with their high prevalence, morbidity and mortality and ease sufferings."
